Vitamin D level after allogeneic hematopoietic stem cell transplant

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 7, 2011, Pages 1079-1083

  Sproat, Lisa ^a   Bolwell, Brian ^b   Rybicki, Lisa ^c   Dean, Robert ^b   Sobecks, Ronald ^b   Pohlman, Brad ^b   Andresen, Steven ^b   Sweetenham, John ^b   Copelan, Edward ^b   Kalaycio, Matt ^b  

^a Banner Blood and Marrow Transplant Program   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Acute leukemia; Osteopenia; Osteoporosis; Stem cell transplant; Vitamin D

Indexed keywords

BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE; PARATHYROID HORMONE; THYMOCYTE ANTIBODY; VITAMIN D;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPENIA; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; REDUCED INTENSITY CONDITIONING; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WHOLE BODY RADIATION;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; BONE DENSITY; BONE DISEASES, METABOLIC; DIETARY SUPPLEMENTS; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LENGTH OF STAY; LEUKEMIA, MYELOID, ACUTE; MALE; MALNUTRITION; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; POSTOPERATIVE COMPLICATIONS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 79958763758     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2010.12.704     Document Type: Article

References (16)

1. Holick M. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
2. Rizzo J., Wingard J., Tichelli A., et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations for the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2006, 12:138-151.
3. Massenkeil G., Fiene C., Rosen O., Michael R., Reisinger W., Arnold R. Loss of bone mass and vitamin D deficiency after hematopoietic stem cell transplantation: standard prophylactic measures fail to prevent osteoporosis. Leukemia 2001, 15:1701-1705.
4. Eberling P., Thomas D., Erbas B., Hopper J., Szer J., Grigg A. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation. J Bone Miner Res 1999, 14:342-350.
5. Casteneda S., Carmona L., Carbajal I., Arranz R., Garcia-Vadillo A. Reduction of bone mass in women after bone marrow transplantation. Calcif Tissue Int 1997, 60:343-347.
6. Kashyap A., Kandeel F., Yamauchi D., et al. Effects of allogeneic bone marrow transplantation on recipient bone mineral density: a prospective study. Biol Blood Marrow Transplant 2000, 6:344-351.
7. Shane E. Transplantation osteoporosis. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism 1999, Vol. 1. Lippincott Williams & Wilkins, Philadelphia, PA. 4th ed. M. Favus (Ed.).
8. Weilbaecher K.N. Mechanisms of osteoporosis after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000, 6:165-174.
9. Arekat M., And G., Lemke S., Moses A. Dramatic improvement of BMD following vitamin D therapy in a bone marrow transplant patient. J Clin Sensitom 2002, 5:267-271.
10. Campos D., Funke V., Biagini G., et al. Bone mineral density, lean body mass, calcium and vitamin D intake in children and adolescents after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2009, 15(Suppl 2):79.
11. Trump D.L., Muindi J., Fakih M., Yu W., Johnson C. Vitamin D compounds: clinical development as cancer therapy and prevention agents. Anticancer Res 2006, 26:255-2556.
12. Ferraro D., Campa E., Dellacasa C., Campana S., Foli C., Boccadoro M. Differentiating agent + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome. Haematologica 2004, 89:5.
13. Yamada K., Mizusawa M., Kajiwara K., et al. Induction of remission of relapsed acute myeloid leukemia after unrelated donor cord blood transplantation by concomitant low-dose cytarabine and calcitriol in adults. Eur J Haematol 2006, 77:345-348.
14. Grant W.B. Solar ultraviolet-B irradiance and vitamin D may reduce risk the risk of septicemia. Dermatoendocrinology 2009, 1:37-42.
15. Drake M.T., Maurer M.J., Link B.K., et al. Vitamin D insufficiency and prognosis in non-Hodgkin's lymphoma. J Clin Oncol 2010, 28:4191-4198.
16. Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009, 94:26-34.